Rakuten Medical Finalizes Exclusive Manufacturing Rights for IR700 Technology
February 5, 2025 - 11:27
Rakuten Medical, a pioneering biotechnology firm, has successfully completed the technology transfer for the manufacturing of its innovative IR700 compound. This strategic move not only solidifies the company’s leading position in the production of this groundbreaking therapy but also ensures an exclusive supply chain for IR700, a key component in their Alluminox™ platform.
The Alluminox™ platform is designed to enhance the efficacy of cancer treatments by delivering targeted therapy directly to tumor cells. With this new manufacturing capability, Rakuten Medical is poised to accelerate the development and commercialization of its cell-targeting therapies, which hold the potential to significantly improve patient outcomes.
The completion of this technology transfer marks a significant milestone for the company, enabling them to maintain control over the quality and consistency of IR700 production. This development is expected to bolster Rakuten Medical's growth trajectory in the competitive biopharmaceutical landscape, as they continue to innovate and expand their therapeutic offerings.
MORE NEWS
August 21, 2026 - 02:08
California names former 18F official as chief technology officerCalifornia has named Ayushi Roy as its new chief technology officer, filling a vacancy left by Jonathan Porat, who stepped down in April. Roy brings experience from the federal level, having...
August 20, 2026 - 01:52
Oregon’s new privacy chief says it’s ‘Groundhog Day’ after time in NevadaWhen Michael Hanna-Butros Meyering took over as Oregon`s first chief privacy officer, he expected some differences from his previous role in Nevada. What he found instead felt like a rerun....
August 19, 2026 - 12:31
CACI opens new defense technology manufacturing facility in RochesterCACI International has officially opened a new manufacturing facility in Rochester, a move that brings advanced defense technology development, testing, and assembly under one roof. The site is...
August 18, 2026 - 19:48
Gorilla Technology Rises 3% as AI Infrastructure Momentum Builds: How GRRR Compares With PalantirA fresh analyst call has put Gorilla Technology in the spotlight, with a bullish price target of $44 set on shares that currently trade around the $15 mark. The stock responded with a 3% gain as...